Last updated 2026-06-18
- Acquired by Merck, Jul 2015
- Raised $8M funding round, Sep 2012
Total raised
$8.0M
Last: 2012-09
Stage
Acquired
Founded
2010
Headcount
1-10
HQ
Hod HaSharon, Israel
Sector
—
About
cCAM Biotherapeutics is a preclinical-stage company focused on the discovery and development of novel immunotherapies to treat cancer. The company's lead product, CM-24, is a phase 1 monoclonal antibody that inhibits the immunosuppressive effect of CEAC AM1, leading to an enhanced anti-tumor immune response of T and NK cells. cCAM Biotherapeutics' activity has been fully integrated into Merck & Co. Inc.
Funding history · 1 round · $8.0M total
2012-09
Q&A
- What is cCAM Biotherapeutics' primary focus?
- cCAM Biotherapeutics is a preclinical-stage company focused on the discovery and development of novel immunotherapies to treat cancer.
- What is cCAM Biotherapeutics' lead product?
- cCAM Biotherapeutics' lead product is CM-24, a phase 1 monoclonal antibody designed to inhibit the immunosuppressive effect of CEAC AM1, thereby enhancing the anti-tumor immune response of T and NK cells.
- When was cCAM Biotherapeutics founded?
- cCAM Biotherapeutics was founded in January 2010.
- What is the current status of cCAM Biotherapeutics?
- cCAM Biotherapeutics is currently inactive, having been acquired by Merck in July 2015, and its activity has been fully integrated into Merck & Co. Inc.
- How much funding has cCAM Biotherapeutics raised in total?
- cCAM Biotherapeutics has raised a total of $8,000,000 USD.
- When was cCAM Biotherapeutics' last funding round and who were the investors?
- cCAM Biotherapeutics' last funding round occurred in September 2012, with participation from Arkin Tech and OrbiMed
- What is the employee count for cCAM Biotherapeutics?
- cCAM Biotherapeutics has an employee count in the 1-10 range.
- In which sector does cCAM Biotherapeutics operate?
- cCAM Biotherapeutics operates in the Health Tech & Life Sciences, Pharma & Medical Biotechnology, and Drugs Discovery & Development sectors.
Sectors & technology
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
therapeuticscancerpharmaceuticalsimmunologytreatmentspharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/6015961 |
Identifiers & details
| Founded | 2010-1 |
|---|---|
| Status reason | Acquired (Inactive) by Merck on Jul 2015 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Merck 2015-07
Radar intelligence
Patents
| EPO | 4 |
|---|